Motor complications in an incident Parkinson's disease cohort
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background and purpose: Levodopa treatment in Parkinson's disease (PD) causes motor fluctuations and dyskinesias, but few data describe their development or severity in unselected incident cohorts. Methods: Demographic, clinical, treatment, smoking, caffeine and alcohol data from 183 people with PD were gathered from the Parkinsonism Incidence in Northeast Scotland (PINE) study, a community‐based, incident cohort. With Kaplan–Meier survival analysis and Cox regression modelling the development, and severity, of dyskinesias and motor fluctuations and which factors independently influenced their onset were assessed. Results: After a mean follow‐up of 59 months, 39 patients (21.3%) developed motor fluctuations and 52 (28.4%) developed dyskinesias. Kaplan–Meier estimates of the probability of motor fluctuations and dyskinesias after 5 years of dopaminergic treatment were 29.2% [95% confidence interval (CI) 21.5%–38.8%] and 37.0% (95% CI 28.5%–47.1%) respectively. 19.8% developed motor fluctuations requiring treatment changes but only 4.0% (95% CI 1.5%–10.4%) developed dyskinesias requiring treatment changes by 5 years. Cumulative levodopa dose [hazard ratio (HR) 1.38 (95% CI 1.19–1.60)], female sex [HR 2.41 (1.19–4.89)] and younger age at diagnosis [HR 1.08 (1.04–1.11)] were independently associated with development of motor fluctuations. Cumulative levodopa dose [HR 1.23 (1.08–1.40)] and female sex [HR 2.51 (1.40–4.51)] were independently associated with dyskinesias. In exploratory analyses, moderate caffeine exposure was associated with fewer motor fluctuations, longer symptom duration with more dyskinesias, and tremor at diagnosis with higher rates of both complications. Conclusions: In this community‐based incident PD cohort, severe dyskinesias were rare. Cumulative levodopa dose was the strongest predictor of both dyskinesias and motor fluctuations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peduzzi, P., Concato, J., Feinstein, A. R., & Holford, T. R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00048-8 · Cited by 2,154 · cited 1×
“This ensured no fewer than about 10 events per variable in the main models [27].”
Background
Cited by
An update on the diagnosis and treatment of Parkinson disease
Rizek, P., Kumar, N., & Jog, M. S. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.151179 · Cited by 447
Risk factors for non-motor symptoms in Parkinson's disease
Marinus, J., Zhu, K., Marras, C., Aarsland, D., & van Hilten, J. J. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30127-3 · Cited by 348
Sex differences in movement disorders
Meoni, S., Macerollo, A., & Moro, E. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0294-x · Cited by 207
Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial
Postuma, R. B., Anang, J., Pelletier, A., Joseph, L., Moscovich, M., Grimes, D., Furtado, S., Munhoz, R. P., Appel-Cresswell, S., Moro, A., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004568 · Cited by 135
The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
Hong, C. T., Chan, L., & Bai, C.-H. (2020) · Nutrients · doi:10.3390/nu12061860 · Cited by 113
“[28] GB 183 Newly diagnosed Verbal interview about the average level of exposure before baseline Cups of tea: 47 mg caffeine Cup of coffee: 62 mg caffeine 59 months 1.”
Background
Metadata
- Authors
- Scott, N. W., Macleod, A. D., & Counsell, C. E.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2015-06-13
- Volume
- 23
- Issue
- 2
- Pages
- 304-312
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W1911883142
- Cited by
- 69
- References
- 1
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Motor complications in an incident Parkinson's disease cohort. https://app.cochat.ai/papers/10.1111/ene.12751
- The paper
- Scott, N. W., Macleod, A. D., & Counsell, C. E. (2016). Motor complications in an incident Parkinson's disease cohort. European Journal of Neurology. https://doi.org/10.1111/ene.12751
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.